Foundation for the National Institutes of Health

Contributor Information:

Funds received by the foundation are used to support an initiative to augment the current drug and medical device safety monitoring approach and to actively and systematically assess the risks and benefits of marketed drugs and devices.

• Abbott
• Amgen Inc.
• AstraZeneca
• Bayer Healthcare Pharmaceuticals, Inc.
  
• Bristol-Myers Squibb
  
• Eli Lilly & Company
• GlaxoSmithKline
• Johnson & Johnson
• Lunbeck, Inc.
  
• Merck & Co., Inc.
• Novartis Pharmaceuticals Corporation
• Pfizer Inc
• Pharmaceutical Research Manufacturers of America (PhRMA)
• Roche
  
• Sanofi-Aventis
• Schering-Plough Corporation
  

Related Links:

Program Information

OMOP web site